We are live on ! Find out more
MLAB icon

Mesa Laboratories

166 hedge funds and large institutions have $634M invested in Mesa Laboratories in 2024 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 17

49% more capital invested

Capital invested by funds: $424M → $634M (+$209M)

8% more funds holding

Funds holding: 154166 (+12)

0% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 50

0.23% less ownership

Funds ownership: 90.68%90.45% (-0.23%)

Holders
166
Holders Change
+12
Holders Change %
+7.79%
% of All Funds
2.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
29
Increased
50
Reduced
50
Closed
17
Calls
Puts
Net Calls
Net Calls Change

MLAB Hedge Fund Activity: Q3 2024 in Review

166 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q3 2024, worth a combined $634M — up 49% from $424M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new MLAB positions and 17 closed out — a net gain of 12 holders — while 50 added to existing stakes and 50 trimmed.

The largest buyer was BlackRock, adding an estimated $3.92M. The largest seller was Royce & Associates, cutting an estimated $5.57M.

  • 166 institutional investors held Mesa Laboratories (MLAB) as of Q3 2024, up from 154 in Q2 2024.
  • Funds reported $634M of Mesa Laboratories stock for Q3 2024, up 49% quarter-over-quarter.
  • 29 funds opened new Mesa Laboratories positions in Q3 2024 and 17 closed out, a net change of +12 holders.
  • The largest Mesa Laboratories buyer in Q3 2024 was BlackRock, an estimated $3.92M added.
  • The largest Mesa Laboratories seller in Q3 2024 was Royce & Associates, an estimated $5.57M sold.

Based on aggregated 13F filings for Q3 2024.